VERTEX PHARMACEUTICALS INC / MA Increase (Decrease) in Inventories
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Increase (Decrease) in Inventories of $125.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for the quarter ending 2026-06-30 was $27.70M, a 81.36% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for the quarter ending 2026-03-31 was $97.70M, a 41.53% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for the quarter ending 2025-12-31 was $77.40M, a 47.53% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for the quarter ending 2025-09-30 was $131.10M, a 28.16% decline year-over-year.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for fiscal 2025 was $524.20M, a 1.33% increase from fiscal 2024.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for fiscal 2024 was $517.30M, a 60.20% increase from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for fiscal 2023 was $322.90M, a 136.73% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA increase (decrease) in inventories for fiscal 2022 was $136.40M, a 46.98% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 6 month as first filed | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 9 month as first filed | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $125.40M 10-Q · filed 2026-08-04 | $202.80M derived: sum of 3 quarters · filed 2026-08-04 | $333.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $97.70M 10-Q · filed 2026-05-05 | $175.10M derived: sum of 2 quarters · filed 2026-05-05 | $306.20M derived: sum of 3 quarters · filed 2026-05-05 | $454.80M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $77.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $208.50M derived: sum of 2 quarters · filed 2026-02-13 | $357.10M derived: sum of 3 quarters · filed 2026-08-04 | $524.20M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $131.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $279.70M derived: sum of 2 quarters · filed 2026-08-04 | $446.80M 10-Q · filed 2025-11-04 | $594.30M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $148.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $315.70M 10-Q · filed 2026-08-04 | $463.20M derived: sum of 3 quarters · filed 2026-08-04 | $645.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $167.10M 10-Q · filed 2026-05-05 | $314.60M derived: sum of 2 quarters · filed 2026-05-05 | $497.10M derived: sum of 3 quarters · filed 2026-05-05 | $604.30M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $147.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $330.00M derived: sum of 2 quarters · filed 2026-02-13 | $437.20M derived: sum of 3 quarters · filed 2026-02-13 | $517.30M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $182.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $289.70M derived: sum of 2 quarters · filed 2025-11-04 | $369.80M 10-Q · filed 2025-11-04 | $439.80M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $107.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $187.30M 10-Q · filed 2025-08-05 | $257.30M derived: sum of 3 quarters · filed 2026-02-13 | $354.80M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $80.10M 10-Q · filed 2025-05-06 | $150.10M derived: sum of 2 quarters · filed 2026-02-13 | $247.60M derived: sum of 3 quarters · filed 2026-02-13 | $320.40M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $70.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $167.50M derived: sum of 2 quarters · filed 2026-02-13 | $240.30M derived: sum of 3 quarters · filed 2026-02-13 | $322.90M 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $97.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $170.30M derived: sum of 2 quarters · filed 2024-11-05 | $252.90M 10-Q · filed 2024-11-05 | $331.20M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $72.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $155.40M 10-Q · filed 2024-08-02 | $233.70M derived: sum of 3 quarters · filed 2025-02-13 | $260.50M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $82.60M 10-Q · filed 2024-05-07 | $160.90M derived: sum of 2 quarters · filed 2025-02-13 | $187.70M derived: sum of 3 quarters · filed 2025-02-13 | $221.00M derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $78.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $105.10M derived: sum of 2 quarters · filed 2025-02-13 | $138.40M derived: sum of 3 quarters · filed 2025-02-13 | $136.40M 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $26.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $60.10M derived: sum of 2 quarters · filed 2023-11-07 | $58.10M 10-Q · filed 2023-11-07 | $85.10M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $33.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $31.30M 10-Q · filed 2023-08-02 | $58.30M derived: sum of 3 quarters · filed 2024-02-15 | $76.60M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | -$2.00M 10-Q · filed 2023-05-02 | $25.00M derived: sum of 2 quarters · filed 2024-02-15 | $43.30M derived: sum of 3 quarters · filed 2024-02-15 | $68.00M derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $27.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $45.30M derived: sum of 2 quarters · filed 2024-02-15 | $70.00M derived: sum of 3 quarters · filed 2024-02-15 | $92.80M 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $18.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $43.00M derived: sum of 2 quarters · filed 2022-10-28 | $65.80M 10-Q · filed 2022-10-28 | $65.83M 10-Q · filed 2021-11-03 | $102.89M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-06-30 | $24.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $47.50M 10-Q · filed 2022-08-05 | $47.49M 10-Q · filed 2021-07-30 | $84.59M derived: sum of 3 quarters · filed 2023-02-10 | $115.11M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2021-03-31 | $22.80M 10-Q · filed 2022-05-06 | $22.79M 10-Q · filed 2021-04-30 | $59.89M derived: sum of 2 quarters · filed 2023-02-10 | $90.41M derived: sum of 3 quarters · filed 2023-02-10 | $127.35M derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $37.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $67.61M derived: sum of 2 quarters · filed 2023-02-10 | $104.55M derived: sum of 3 quarters · filed 2023-02-10 | $132.00M 10-K · filed 2023-02-10 | $132.01M 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $30.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $67.46M derived: sum of 2 quarters · filed 2021-11-03 | $94.91M 10-Q · filed 2021-11-03 | $113.63M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $36.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $64.39M 10-Q · filed 2021-07-30 | $83.11M derived: sum of 3 quarters · filed 2022-02-09 | $103.21M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $27.45M 10-Q · filed 2021-04-30 | $46.17M derived: sum of 2 quarters · filed 2022-02-09 | $66.28M derived: sum of 3 quarters · filed 2022-02-09 | $78.31M derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $18.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $38.83M derived: sum of 2 quarters · filed 2022-02-09 | $50.86M derived: sum of 3 quarters · filed 2022-02-09 | $64.00M 10-K · filed 2022-02-09 | $64.05M 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $20.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $32.14M derived: sum of 2 quarters · filed 2020-10-30 | $45.28M 10-Q · filed 2020-10-30 | $52.78M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $12.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $25.17M 10-Q · filed 2020-07-31 | $32.68M derived: sum of 3 quarters · filed 2021-02-11 | $47.77M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $13.14M 10-Q · filed 2020-05-01 | $20.64M derived: sum of 2 quarters · filed 2021-02-11 | $35.74M derived: sum of 3 quarters · filed 2021-02-11 | $36.90M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $22.60M derived: sum of 2 quarters · filed 2021-02-11 | $23.76M derived: sum of 3 quarters · filed 2021-02-11 | $31.96M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $15.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $16.25M derived: sum of 2 quarters · filed 2019-10-31 | $24.46M 10-Q · filed 2019-10-31 | $41.72M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $9.37M 10-Q · filed 2019-08-01 | $26.62M derived: sum of 3 quarters · filed 2020-02-13 | $33.85M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $8.21M 10-Q · filed 2019-05-01 | $25.47M derived: sum of 2 quarters · filed 2020-02-13 | $32.69M derived: sum of 3 quarters · filed 2020-02-13 | $47.80M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $17.26M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $24.49M derived: sum of 2 quarters · filed 2020-02-13 | $39.59M derived: sum of 3 quarters · filed 2020-02-13 | $47.48M 10-K · filed 2020-02-13 | $44.98M 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $7.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $22.33M derived: sum of 2 quarters · filed 2018-10-25 | $30.23M 10-Q · filed 2018-10-25 | $28.57M 10-Q · filed 2017-10-30 | $38.06M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | $15.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $23.00M 10-Q · filed 2018-07-26 | $22.03M 10-Q · filed 2017-07-28 | $30.83M derived: sum of 3 quarters · filed 2019-02-13 | $34.59M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-03-31 | $7.89M 10-Q · filed 2018-04-27 | $3.65M 10-Q · filed 2017-04-28 | $15.73M derived: sum of 2 quarters · filed 2019-02-13 | $19.48M derived: sum of 3 quarters · filed 2019-02-13 | $22.49M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | $7.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $11.59M derived: sum of 2 quarters · filed 2019-02-13 | $14.60M derived: sum of 3 quarters · filed 2019-02-13 | $19.37M 10-K · filed 2019-02-13 | $16.45M 10-K · filed 2017-02-23 | |||
| 2016-09-30 | $3.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-30 | $6.76M derived: sum of 2 quarters · filed 2017-10-30 | $11.54M 10-Q · filed 2017-10-30 | $18.55M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $7.78M 10-Q · filed 2017-07-28 | $14.80M derived: sum of 3 quarters · filed 2018-02-15 | $21.50M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $4.77M 10-Q · filed 2017-04-28 | $11.79M derived: sum of 2 quarters · filed 2018-02-15 | $18.49M derived: sum of 3 quarters · filed 2018-02-15 | $25.28M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $7.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $13.72M derived: sum of 2 quarters · filed 2018-02-15 | $20.51M derived: sum of 3 quarters · filed 2018-02-15 | $23.15M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-31 | $13.49M derived: sum of 2 quarters · filed 2016-10-31 | $16.13M 10-Q · filed 2016-10-31 | $27.70M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | $6.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $9.43M 10-Q · filed 2016-08-01 | $20.99M derived: sum of 3 quarters · filed 2017-02-23 | $27.09M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | $2.63M 10-Q · filed 2016-05-03 | $14.20M derived: sum of 2 quarters · filed 2017-02-23 | $20.30M derived: sum of 3 quarters · filed 2017-02-23 | $21.59M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $11.57M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $17.66M derived: sum of 2 quarters · filed 2017-02-23 | $18.96M derived: sum of 3 quarters · filed 2017-02-23 | $16.47M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | $6.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $7.39M derived: sum of 2 quarters · filed 2015-10-30 | $4.90M 10-Q · filed 2015-10-30 | $2.97M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$1.19M 10-Q · filed 2015-08-04 | -$3.12M derived: sum of 3 quarters · filed 2016-02-16 | -$1.72M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | -$2.49M 10-Q · filed 2015-05-04 | -$4.42M derived: sum of 2 quarters · filed 2016-02-16 | -$3.01M derived: sum of 3 quarters · filed 2016-02-16 | -$399.00K derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | -$522.00K derived: sum of 2 quarters · filed 2016-02-16 | $2.09M derived: sum of 3 quarters · filed 2016-02-16 | -$7.14M 10-K · filed 2016-02-16 | ||||
| 2013-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $4.02M derived: sum of 2 quarters · filed 2014-11-06 | -$5.21M 10-Q · filed 2014-11-06 | $5.21M 10-Q · filed 2013-11-07 | $57.13M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$6.62M 10-Q · filed 2014-07-31 | $6.62M 10-Q · filed 2013-08-02 | $55.72M derived: sum of 3 quarters · filed 2015-02-13 | $57.59M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | -$9.23M 10-Q · filed 2014-05-05 | $53.11M derived: sum of 2 quarters · filed 2015-02-13 | $54.98M derived: sum of 3 quarters · filed 2015-02-13 | $3.78M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | $62.34M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | $64.21M derived: sum of 2 quarters · filed 2015-02-13 | $13.01M derived: sum of 3 quarters · filed 2015-02-13 | $29.93M 10-K · filed 2015-02-13 | ||||
| 2012-09-30 | $1.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$49.33M derived: sum of 2 quarters · filed 2013-11-07 | -$32.42M 10-Q · filed 2013-11-07 | $32.42M 10-Q · filed 2012-11-06 | $12.14M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-06-30 | -$51.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$34.29M 10-Q · filed 2013-08-02 | $34.29M 10-Q · filed 2012-08-08 | $10.28M derived: sum of 3 quarters · filed 2014-02-11 | $25.01M derived: sum of 4 quarters · filed 2014-02-11 | |||
| 2012-03-31 | $16.91M 10-Q · filed 2013-05-08 | $61.48M derived: sum of 2 quarters · filed 2014-02-11 | $76.22M derived: sum of 3 quarters · filed 2014-02-11 | $110.64M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $44.56M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $59.30M derived: sum of 2 quarters · filed 2014-02-11 | $93.73M derived: sum of 3 quarters · filed 2014-02-11 | $111.39M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $14.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $49.16M derived: sum of 2 quarters · filed 2012-11-06 | $66.82M 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | $34.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $52.09M 10-Q · filed 2012-08-08 | ||||||
| 2011-03-31 | $17.66M 10-Q · filed 2012-05-10 | |||||||
| 2010-12-31 | $0.00 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |